Patients on atypical antipsychotic drugs: Another high-risk group for type 2 diabetes

被引：3

作者：

Lean, MEJ

Pajonk, FG

机构：

[1] Univ Glasgow, Dept Human Nutr, Glasgow, Lanark, Scotland

[2] Saarland Univ Hosp, Dept Psychiat & Psychotherapy, Homburg, Germany

来源：

DIABETES CARE | 2003年 / 26卷 / 11期

关键词：

D O I：

10.2337/diacare.26.11.3202

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3202 / 3203

页数：2

共 17 条

[11]

KOLLER EA, 2002, END SOC M SAN FRAN C

[12] Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study [J].

Koro, CE ;

Fedder, DO ;

L'Italien, GJ ;

Weiss, SS ;

Magder, LS ;

Kreyenbuhl, J ;

Revicki, DA ;

Buchanan, RW .

BMJ-BRITISH MEDICAL JOURNAL, 2002, 325 (7358) :243-245

[13]

LAGE MJ, 2001, IPS CONV ORL FL

[14] Patients on atypical antipsychotic drugs - Another high-risk group for type 2 diabetes [J].

Lean, MEJ ;

Pajonk, FG .

DIABETES CARE, 2003, 26 (05) :1597-1605

[15]

LEE DW, 2003, BEHAV HLTH TRENDS, P46

[16] Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia [J].

Newcomer, JW ;

Haupt, DW ;

Fucetola, R ;

Melson, AK ;

Schweiger, JA ;

Cooper, BP ;

Selke, G .

ARCHIVES OF GENERAL PSYCHIATRY, 2002, 59 (04) :337-345

[17]

Newcomer JW, 2002, BIOL PSYCHIAT, V51, p25S

← 1 2 →